Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

December 4, 2008
EVIDEM: Transparent Approaches to Healthcare Decisionmaking
Speakers for this event:
  • Mireille M. Goetghebeur PhD, VP Operations, BioMedCom Consultants Inc., Montreal, Québec, Canada  Learn More
  • Donna Rindress PhD, President & Managing Director, BioMedCom Consultants Inc., Montreal, Québec, Canada  Learn More
  • Cheri Deal PhD MD FRCPC, Professor of Pediatrics and Program Director, Pediatric Endocrinology and DiabetesUniversity of Montreal/Centre Hospitalier Universitaire Ste-Justine, Montreal, Québec, Canada    Learn More
  • Jacqui Miot BPharm PhD, Division Manager, Health Economics UnitDiscovery Health, Johannesburg, South Africa  Learn More
  • Paul Oh MD FRCPC, Medical Director Cardiac Rehab Program, Toronto Rehab, Toronto, Ontario, Canada  Learn More
  • EVIDEM: Transparent Approaches to Healthcare Decisionmaking

    Healthcare decision-making is a complex process. Transparency of the evidence and values underlying healthcare decisions can be achieved through structured approaches relying on international standards and local needs.

     

    EVIDEM is a comprehensive and pragmatic decision-support platform applying principles of MultiCriteria Decision Analysis (MCDA). This webinar provides an overview of EVIDEM concept, platform and tools in the context of current challenges in healthcare decisionmaking. EVIDEM was developed to support transparent and efficient decisionmaking through systematic assessment of evidence and values of healthcare interventions.

     

    The presentation will be followed by a hands-on online exercise applying an EVIDEM tool to assess the value of a sample intervention. Three policy and clinical decisionmakers will then discuss their perspectives on current unmet needs and field experience, focusing on challenges and opportunities of structured approaches such as EVIDEM to promote efficient decisionmaking.

     

    Expected outcomes:  Participants will leave this workshop with a basic knowledge of EVIDEM and hands-on experience in its application. Presentations from the field and discussions should stimulate ideas for application of transparent approaches to decision support by participants in their own environments.

     

    To learn more about EVIDEM, visit http://www.evidem.org/

    THIS PROGRAM IS INTENDED FOR:

    The EVIDEM webinar is intended for all stakeholders in healthcare decisionmaking worldwide.

    These include:

    • Healthcare policy decisionmakers (members of decisionmaking committee(s) or advisory committee(s))
    • MDs (specialists, general practitioners)
    • Healthcare professionals and nurses
    • Pharmacists
    • Researchers (clinicians, health economists, epidemiologists)
    • Developers of new healthcare interventions (manufacturers of pharmaceuticals, biomedical devices etc…)
    ABOUT OUR SPEAKERS:

    Mireille M. Goetghebeur PhD, VP Operations, BioMedCom Consultants Inc., Montreal, Québec, Canada  

    Trained in biochemistry and nutrition at the University of Montpellier and the Institute of Engineering Sciences of Montpellier in France, Mireille moved to Macdonald College, McGill University where her research focused on applied biotechnology. From there, Mireille joined the International Scientific and Information Service at Benefit-Quintiles where she focused on applied health outcomes and health economics. Subsequently co-founding BioMedCom Consultants, she was responsible for establishing the procedures and tools that integrate BioMedCom operations and facilitate evidence-based documentation. Mireille’s experience encompasses an array of therapeutic and treatment areas. As well as managing many of BioMedCom’s projects, both regional and international, Mireille participates in study strategy, design and implementation. She is Principal Investigator for the EVIDEM Group and the INTERFACE Project. Her research interests focus on the development of efficient tools, processes and information systems that facilitate healthcare decisionmaking at all levels.

    Donna Rindress PhD, President & Managing Director, BioMedCom Consultants Inc., Montreal, Québec, Canada  

    Donna's original research and training was at McGill University in cellular endocrinology and signal transduction with a focus on diabetes; she later pursued this work with Merck at their research center in Montreal. Moving on to work in the nascent fields health outcomes and health economics, it became clear that there was a need for scientifically rigorous, transparent application. Donna established the ISIS group at Benefit-Quintiles with this in mind, and in 1996, BioMedCom was founded to carry on this practice, serving all stakeholders in the healthcare community. Since its inception, BioMedCom has been a leader in application of health outcomes and health economics research to healthcare decisionmaking, promoting evidence-based rationales for adoption of new healthcare technologies. Donna serves a strategic leadership role at BioMedCom, maintaining business and customer relations, and participating in project planning and quality oversight. She has been part of the EVIDEM project from its inception.

      Cheri Deal PhD MD FRCPC, Professor of Pediatrics and Program Director, Pediatric Endocrinology and DiabetesUniversity of Montreal/Centre Hospitalier Universitaire Ste-Justine, Montreal, Québec, Canada    

    Cheri Deal obtained her PhD from McGill University and her MD at the Université de Montréal (UdM). She did residencies at the Montreal Children’s and Ste-Justine hospitals and pursued her research at Stanford University. She is on staff at Ste-Justine Hospital and professor in the Department of Pediatrics at UdM. Her past and present affiliations include: vice-president of the Royal College Endocrinology Examination Board, member of the Finance Committee for the FRSQ, site leader for the CIHR Canadian Clinical Scientist Training Program, director of Pediatric Endocrinology and Metabolism at the UdM, member for the Growth Hormone Research Society, president-elect of the Canadian Society of Endocrinology and Metabolism, board member and advisor for the Canadian Turner Syndrome Society and the Quebec Turner Association. Dr. Deal’s laboratory is interested in the genetics and the epigenetics of the GH-IGF axis focusing on carcinogenesis and Turner’s syndrome. She has over 75 peer-reviewed publications.

      Jacqui Miot BPharm PhD, Division Manager, Health Economics UnitDiscovery Health, Sandton, South Africa  

    Jacqui Miot has a Pharmacy degree (1989, South Africa) and a PhD in Neuropharmacology (1995, London University). She has worked in the field of Managed Care for over 12 years, mainly with Discovery Health, the largest private healthcare funder in South Africa. She ran Discovery’s Clinical Policies Unit until the end of 2004, and has since headed up the Health Economics Unit in Discovery Health, where HTA, health economic models, and registries play a critical role in clinical decisionmaking. Jacqui serves on the ExCo of the ISPOR South Africa chapter and is current Chairperson of the Pharmaceutical Care Management Association, South Africa. She also continues her academic involvement, assisting and examining Masters and PhD students in related topics. She has a number of publications in medical, pharmaceutical and scientific journals and has presented at both local and international medical, pharmaceutical and health economic forums and conferences.

      Paul Oh MD FRCPC, Medical Director Cardiac Rehab Program, Toronto Rehab, Toronto, Ontario, Canada

    Paul Oh is Medical Director of the Cardiac Rehab and Secondary Prevention Program at the Toronto Rehabilitation Institute and Staff Physician in the Department of Medicine at Sunnybrook Health Sciences Centre. He obtained his MD from the University of Toronto in 1988 and completed specialty training in Internal Medicine, Clinical Pharmacology and Clinical Epidemiology in Toronto, with a focus on the management and evaluation of risk factors and cardiovascular disease, and economic evaluation of health care technologies. In the Cardiac Rehab Program he provides leadership in education, research, clinical care and program development.  He is a prior member and Chair of the Drug Quality and Therapeutics Committee (DQTC) of Ontario and has participated in guidelines and strategic development processes for health technology evaluation provincially and federally.

    ABOUT OUR SPONSORING PARTNER:


    BioMedCom™ Consultants inc.
    is a contract research organization specializing in the application of health outcomes and health economic research. One of the primary applications of such research is its use in healthcare decisionmaking, and much of our work involves developing rigorous, evidence-based materials to help guide healthcare decisions. Our strengths lie in desktop research, data synthesis and analysis, and dissemination of health outcomes information to all its important audiences.

    All Senior Associates at BioMedCom have rigorous scientific training at and beyond the doctoral level and are skillful, experienced communicators. We work effectively as a team to provide high quality, scientifically rigorous, and persuasive resources. Our standard procedures incorporate the requirements and expectations of both scientific & decisionmaking communities, and no product leaves BioMedCom™ without critical review and refinement.

    As evidenced by our steady growth over the last decade and repeat recommendations from our clients, we are a financially and socially stable organization with a strong commitment to quality, timeliness and teamwork. Our client base is spread across many of the major international companies in the healthcare industry, academic and medical centers, and professional associations, the global offices as well as their local offices in key regions around the world, including Canada, the US, the UK, Europe, and Asia.

    The EVIDEM study was made possible by an unrestricted research grant from Pfizer Canada.

    ABOUT OUR MEDIA PARTNERS:

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 17,500 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.

    AccessFYI is a comprehensive Web portal designed specifically for professionals in the life sciences industry. This includes people who operate in the pharmaceutical, biotechnology, and medical device sectors, as well as those who provide services and tools to the industry.

    Most of the information available on AccessFYI is free. You'll find podcasts, videos, webinars, workshops, whitepapers, conferences, and even job listings.

    If you are looking for information that will help you through your toughest challenges, or if you offer content to the industry, register your free account and start benefiting from everything AccessFYI has to offer.

    For information about the recorded archive for this event contact Xtalks at (416) 977-6555 ext 371, or email register@xtalks.com

     
    Copyright © 2016-2017 Honeycomb Worldwide Inc.